MYO-301

N/A

Report date: 2024/12/20 17:22:29

Base Information

Drug NameMYO-301
Drug Alias NameMYO-301SRP-9006
ClassificationCell and gene therapy > Gene therapy
Mechanisms of ActionAnoctamin-5 gene transference
TargetsAnoctamin-5
Therapy Area/IndicationsMuscular Dystrophies, Limb-Girdle
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesSarepta Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesSarepta Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsMuscular Dystrophies, Limb-Girdle
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A